Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cisco Systems

Magna International

These shares may not stay this cheap for long.

3 Cheap Dividend Stocks That Report Earnings in February

Lyft

NVIDIA

Roku

Shopify

The fourth-quarter earnings reporting season has reached a peak, but many more major companies will be sharing their results soon.

Cisco, CVS, Lyft, Nvidia, Shopify, Roku and More Major Earnings Coming This Week

Alibaba

These seven earnings reports next week are worth highlighting. Here's what you might expect when each of these companies makes their report.

7 Earnings Reports to Watch Next Week. (Feb 07)

Anthem

Cigna

Express Scripts Holding

Humana

Walgreens

WellCare Health Plans

The U.S. health insurance market, roiled by transformative deals in recent years, will likely face a lull in major deal activity in 2020 while firms await critical federal election outcomes.

Feel The Bern: Presidential Race Throws Cold Water On Health Insurance Mega-Mergers

CVS stock hasn’t looked convincing since 2015 following an expensive buyout. But at these prices, it’s too attractive to ignore.

Fourth-Quarter Earnings Could Set Up CVS Stock for the Rest of 2020

Boston Scientific

Cardinal Health

The markets may be taking a dip, but these three healthcare stocks could be your portfolio's prescription as earnings season is in full swing.

3 Healthcare Stocks to Buy This Week Ahead of Earnings

JPMorgan Chase & Co

Rite Aid

Herbalife

Pharmacies & Drug Stores Industry Outlook: Prospects Mixed

Former Aetna CEO Mark Bertolini said he is being forced off the board of CVS Health, the Wall Street Journal reported on Monday.

Former Aetna CEO Mark Bertolini reportedly said he is getting forced off CVS board

CVS Health: Its Economic Moat Is Underestimated

As the drugstore giant's reach grows, CVS stock price will likely benefit 
The post CVS Stock Is a Long-Term Hold, but It’s not a Buy Ahead of Earnings appeared first on InvestorPlace.
More From InvestorPlace
		
					
				
					2 Toxic Pot Stocks You Should Avoid				
			
					
				
					7 Under-the-Radar European Stocks to Buy for 2020				
			
					
				
					7 Industries Using AI to Benefit Shareholders Around the World				
			
					
				
					5 Chinese Stocks to Buy When Coronavirus Fears Fade

CVS Stock Is a Long-Term Hold, but It’s not a Buy Ahead of Earnings

The pharmacy giant is offering health insurers and employers a tool to eliminate out-of-pocket costs for diabetics that won't raise their costs either.

CVS Announces Plan to Eliminate Co-Pays for Diabetes Drugs

ETRADE

Royal Caribbean Cruises

U.S. equities head into a key week. Monday's big stock charts feature 3 names that, like stocks as a whole, look a bit wobbly at the moment.

3 Big Stock Charts for Monday: CVS, Royal Caribbean, and E*TRADE

AbbVie

Bristol-Myers

Despite an uncertain political year, the credit ratings agency expects merger activity in U.S. healthcare to continue.

Fitch Ratings Says Impeachment Trial Won't Hurt Healthcare Investment in 2020

Centene

iShares U.S. Healthcare Providers ETF

UnitedHealth Group

The iShares U.S. Healthcare Providers ETF (NYSEArca: IHF) scuffled through much of 2019 before gaining some momentum in the fourth quarter.

A Strong Start to 2020 For This Healthcare ETF

Aflac

AutoZone

Carriage Services

Alphabet

H&R Block

IDEXX Laboratories

O'Reilly Automotive

Service Corp

Trupanion

Seemingly every day, the fundamentals surrounding the U.S. economy seem to deteriorate.

10 Recession-Resistant Services Stocks to Buy

Alexion Pharma

Sinclair Inc

Many of these industries have recently been valued at their lowest forward P/E in at least 22 years.

6 Industries That Are Historically Cheap, Even With the Stock Market at an All-Time High

Amazon

Bed Bath & Beyond

While retail stocks are often volatile, these four picks look likely to deliver both in earnings season and in the much longer term.

4 Post-Holiday Retail Stocks Still Worth a Look

CVS has its groove back thanks to the retail expansion of HealthHUBs locations, but CVS stock still isn't priced appropriately.
The post Undervalued CVS Stock Is Set for Another Big Year in 2020 appeared first on InvestorPlace.

Undervalued CVS Stock Is Set for Another Big Year in 2020

Healthcare stocks like, CVS Health Corporation (NYSE:CVS) are going get a lot of attention during this presidential election. 
The post The Prognosis for CVS is Strong appeared first on InvestorPlace.

The Prognosis for CVS is Strong

Lockheed Martin

Microsoft

Oracle

Value Investing Is A Long-Term Strategy And Should Be Judged Accordingly

Chipotle

Target

Ulta Beauty

The leading foot traffic analytics platform thinks these retailers are worth watching.

5 Retail Stocks Placer.ai Thinks Can Win Big in 2020

CVS Health saw its IBD SmartSelect Composite Rating jump to 96 Wednesday, up from 92 the day before. 
The post Stocks With Rising Composite Ratings: CVS Health appeared first on Investor's Business Daily.

Stocks With Rising Composite Ratings: CVS Health

With a focus on health and service, CVS sees a bright future ahead.

Where Will CVS Be in 5 Years?

CVS Health’s top executive said its stores are focused on offering “80% of what a primary care physician can treat” as it rolls out its new HealthHub format and “zero” and “low copays” for CVS services and items for certain Aetna health plan members.

CVS CEO: We’re Scaling More Low Cost Health Offerings In 2020

CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.

News for CVS Health Stock (CVS)